Conatus Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
56,353.00
37,071.90
36,508.10
77,015.10
74,853.20
40,692
Total Accounts Receivable
-
-
-
2,500.00
3,366.60
3,677
Other Current Assets
545.50
796.80
1,982.00
937.40
1,004.20
3,057
Total Current Assets
56,898.50
37,868.80
38,490.10
80,452.60
79,224.00
47,426
Net Property, Plant & Equipment
23.10
237.10
344.70
261.40
178.60
154
Other Assets
14.40
342.10
892.40
1,609.80
2,538.20
1,223
Total Assets
56,936.00
38,447.90
39,727.30
82,323.80
81,940.90
48,803
ST Debt & Current Portion LT Debt
-
-
-
1,000.00
-
Accounts Payable
1,494.40
-
-
5,311.10
11,962.00
Other Current Liabilities
1,322.60
4,175.20
3,982.70
33,248.90
16,180.40
Total Current Liabilities
2,817.00
4,175.20
3,982.70
39,560.00
28,142.30
Long-Term Debt
1,000.00
1,000.00
1,000.00
-
13,157.50
Other Liabilities
-
58.70
204.20
20,975.30
12,644.70
Total Liabilities
3,817.00
5,233.90
5,186.90
60,535.30
53,944.60
Common Equity (Total)
53,119.00
33,213.90
34,540.30
21,788.50
27,996.30
Total Shareholders' Equity
53,119.00
33,213.90
34,540.30
21,788.50
27,996.30
Total Equity
53,119.00
33,213.90
34,540.30
21,788.50
27,996.30
Liabilities & Shareholders' Equity
56,936.00
38,447.90
39,727.30
82,323.80
81,940.90
About Conatus Pharmaceuticals
View Profile
